Growth Metrics

DBV Technologies (DBVT) Revenue (2014 - 2026)

DBV Technologies (DBVT) reported Revenue of $900000.0 for Q1 2026, up 12.5% year-over-year from $800000.0 in Q1 2025, and up 39.53% on a QoQ basis from $645000.0 in Q4 2025.

DBV Technologies (DBVT) has 11 years of Revenue data on file, last reported at $900000.0 in Q1 2026.

  • Quarterly Revenue rose 12.5% year-over-year to $900000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (up 63.21% YoY) and the FY2025 annual result came in at $5.6 million, up 35.77% from the prior year.
  • Revenue grew to $900000.0 in Q1 2026 per DBVT's latest filing, from $645000.0 in the prior quarter.
  • Across five years, Revenue topped out at $8.9 million in Q4 2023 and bottomed at -$1.3 million in Q4 2022.
  • The 5-year median for Revenue is $1.5 million (2025), against an average of $1.8 million.
  • The widest annual swing landed in 2022, when Revenue tumbled 144.47%; it then soared 780.6% in 2023.
  • Tracing DBVT's Revenue over 5 years: stood at -$1.3 million in 2022, then soared by 780.6% to $8.9 million in 2023, then sank by 94.24% to $511000.0 in 2024, then increased by 26.22% to $645000.0 in 2025, then jumped by 39.53% to $900000.0 in 2026.
  • Per Business Quant, the three latest DBVT Revenue figures stand at $900000.0 (Q1 2026), $645000.0 (Q4 2025), and $2.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2.99 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.61 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.17 Bn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn 900,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 900,000.00
Dec 31, 2025 645,000.00
Sep 30, 2025 2.77 Mn
Jun 30, 2025 1.47 Mn
Mar 31, 2025 800,000.00
Dec 31, 2024 511,000.00
Sep 30, 2024 1.07 Mn
Jun 30, 2024 1.16 Mn
Mar 31, 2024 1.41 Mn
Dec 31, 2023 8.88 Mn
Sep 30, 2023 2.37 Mn
Jun 30, 2023 2.29 Mn
Mar 31, 2023 2.19 Mn
Dec 31, 2022 -1.30 Mn
Sep 30, 2022 2.07 Mn
Jun 30, 2022 1.53 Mn
Mar 31, 2022 2.55 Mn
Dec 31, 2021 2.93 Mn
Sep 30, 2021 1.32 Mn
Jun 30, 2021 1.49 Mn
Mar 31, 2021 2.94 Mn
Dec 31, 2020 -1.21 Mn
Sep 30, 2020 4.16 Mn
Jun 30, 2020 3.61 Mn
Mar 31, 2020 4.72 Mn
Sep 30, 2019 11.03 Mn
Dec 31, 2018 -11.71 Mn
Sep 30, 2018 3.46 Mn
Dec 31, 2015 3.47 Mn
Jun 30, 2015 119,355.26
Dec 31, 2014 3.32 Mn
Jun 30, 2014 141,529.15